Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
CompletedNCT06280235
Safety study of BI 1569912 in Depressive Disorder, Major
This study is completed in the United States, in Belgium, in Bulgaria, .... It is testing BI 1569912 for Depressive Disorder, Major.
DepressionDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: March 27, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 243
- Sponsor
- Boehringer Ingelheim
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, Belgium, Bulgaria, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06280235
- Official title
- A Phase II, 6-week, Multicenter, Randomized, Double Blind (Patient and Investigator) or Masked, Placebo Controlled, Dose-finding Trial to Evaluate the Efficacy, Tolerability, and Safety of Different Doses of Oral BI 1569912 as Adjunctive Therapy in MD
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT06280235. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Belgium · 2 sites
- Anima Research CenterAlkenSite status: Not listed — confirm with the team
- Universitair Psychiatrisch Centrum Duffel (UPC Duffel)DuffelSite status: Not listed — confirm with the team
Bulgaria · 7 sites
- Ambulatory for Individual Practice for Specialized Medical Care in Psychiatry - Dr Ivo NatsovCherven BryagSite status: Not listed — confirm with the team
- MHC - Ruse, EOODRousseSite status: Not listed — confirm with the team
- Medical Center "Sv.Naum"SofiaSite status: Not listed — confirm with the team
- DCC "Sv. Vrach and Sv. Sv. Kuzma and Damyan" OODSofiaSite status: Not listed — confirm with the team
- Medical Center Hera EOODSofiaSite status: Not listed — confirm with the team
- Medical Center Intermedica Ltd.SofiaSite status: Not listed — confirm with the team
- DCC Mladost-M Varna OODVarnaSite status: Not listed — confirm with the team
China · 8 sites
- Hebei Mental Health CenterBaodingSite status: Not listed — confirm with the team
- Beijing Anding HospitalBeijingSite status: Not listed — confirm with the team
- Peking University Sixth HospitalBeijingSite status: Not listed — confirm with the team
- The Second Xiangya Hospital Of Central South UniversityChangshaSite status: Not listed — confirm with the team
- Shanghai Mental Health CenterShanghaiSite status: Not listed — confirm with the team
- Shenzhen Kangning HospitalShenzhenSite status: Not listed — confirm with the team
- The First Hospital of Hebei Medical UniversityShijiazhuangSite status: Not listed — confirm with the team
- Tianjin Anding HospitalTianjinSite status: Not listed — confirm with the team
Czechia · 2 sites
- A-SHINE s.r.oPilsenSite status: Not listed — confirm with the team
- Clintrial s.r.o.PragueSite status: Not listed — confirm with the team
Germany · 2 sites
- Charité - Universitätsmedizin BerlinBerlinSite status: Not listed — confirm with the team
- Somni Bene - Institut für Medizinische Forschung & Schlafmedizin Schwerin GmbHSchwerinSite status: Not listed — confirm with the team
Japan · 10 sites
- Iwaki Clinic, Tokushima, Psychosomatic MedicineAnan-shiSite status: Not listed — confirm with the team
- Aisakura ClinicFukuokaSite status: Not listed — confirm with the team
- Kaku Mental ClinicFukuokaSite status: Not listed — confirm with the team
- Mental Clinic SakurazakaFukuokaSite status: Not listed — confirm with the team
- Kuramitsu HospitalFukuokaSite status: Not listed — confirm with the team
- Fukuoka University HospitalFukuoka, FukuokaSite status: Not listed — confirm with the team
- Rainbow and Sea HospitalKaratsu-shiSite status: Not listed — confirm with the team
- Hirota ClinicKurume-shiSite status: Not listed — confirm with the team
- Kyorin University HospitalMitaka-shiSite status: Not listed — confirm with the team
- Maynds Tower Mental ClinicShibuya-kuSite status: Not listed — confirm with the team
United States · 21 sites
- Southwest Biomedical Research, LLCTucson, ArizonaSite status: Not listed — confirm with the team
- Excell Research Inc.Oceanside, CaliforniaSite status: Not listed — confirm with the team
- NRC Research InstituteOrange, CaliforniaSite status: Not listed — confirm with the team
- Asclepes Research Centers-Panorama City-62905Panorama City, CaliforniaSite status: Not listed — confirm with the team
- CT Clinical ResearchCromwell, ConnecticutSite status: Not listed — confirm with the team
- Galiz ResearchHialeah, FloridaSite status: Not listed — confirm with the team
- Premier Clinical Research InstituteMiami, FloridaSite status: Not listed — confirm with the team
- CCM Clinical Research Group, LLC-Miami-68482Miami, FloridaSite status: Not listed — confirm with the team
- iResearch AtlantaDecatur, GeorgiaSite status: Not listed — confirm with the team
- Chicago Research Center, IncorporatedChicago, IllinoisSite status: Not listed — confirm with the team
- ActivMed Practices & ResearchMethuen, MassachusettsSite status: Not listed — confirm with the team
- Boston Clinical TrialsRoslindale, MassachusettsSite status: Not listed — confirm with the team
- Adams ClinicalWatertown, MassachusettsSite status: Not listed — confirm with the team
- Hassman Research Institute-Marlton-66897Marlton, New JerseySite status: Not listed — confirm with the team
- Neurobehavioral Research, Inc.Cedarhurst, New YorkSite status: Not listed — confirm with the team
- Midwest Clinical ResearchDayton, OhioSite status: Not listed — confirm with the team
- Neuro-Behavioral Clinical ResearchNorth Canton, OhioSite status: Not listed — confirm with the team
- Sooner Clinical ResearchOklahoma City, OklahomaSite status: Not listed — confirm with the team
- Houston Clinical Trials, LLCBellaire, TexasSite status: Not listed — confirm with the team
- Grayline Research CenterWichita Falls, TexasSite status: Not listed — confirm with the team
- Northwest Clinical Research CenterBellevue, WashingtonSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving BI 1569912, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with depression; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Boehringer Ingelheim, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT00223496
12- Week Open Label Treatment of Refractory Depression in bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
CompletedNCT02363738
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
This study is completed. It focuses on bipolarity and currently lists study information in Canada and the United States.
CompletedNCT03902613
18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.